Literature DB >> 18082417

Innate immunity, insulin resistance and type 2 diabetes.

José Manuel Fernández-Real1, John C Pickup.   

Abstract

Recent evidence has disclosed previously unrecognized links among insulin resistance, obesity, circulating immune markers, immunogenetic susceptibility, macrophage function and chronic infection. Genetic variations leading to altered production or function of circulating innate immune proteins, cellular pattern-recognition receptors and inflammatory cytokines have been linked with insulin resistance, type 2 diabetes, obesity and atherosclerosis. Cellular innate immune associations with obesity and insulin resistance include increased white blood cell count and adipose tissue macrophage numbers. The innate immune response is modulated possibly by both predisposition (genetic or fetal programming), perhaps owing to evolutionary pressures caused by acute infections at the population level (pandemics), and chronic low exposure to environmental products or infectious agents. The common characteristics shared among innate immunity activation, obesity and insulin resistance are summarized.

Entities:  

Mesh:

Year:  2007        PMID: 18082417     DOI: 10.1016/j.tem.2007.10.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  68 in total

1.  Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study.

Authors:  Wayne Katon; Courtney R Lyles; Melissa M Parker; Andrew J Karter; Elbert S Huang; Rachel A Whitmer
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

2.  Innate immunity, insulin resistance and type 2 diabetes.

Authors:  J M Fernández-Real; J C Pickup
Journal:  Diabetologia       Date:  2011-11-30       Impact factor: 10.122

3.  Integrating pathway analysis and genetics of gene expression for genome-wide association studies.

Authors:  Hua Zhong; Xia Yang; Lee M Kaplan; Cliona Molony; Eric E Schadt
Journal:  Am J Hum Genet       Date:  2010-03-25       Impact factor: 11.025

4.  A model selection approach for expression quantitative trait loci (eQTL) mapping.

Authors:  Ping Wang; John A Dawson; Mark P Keller; Brian S Yandell; Nancy A Thornberry; Bei B Zhang; I-Ming Wang; Eric E Schadt; Alan D Attie; C Kendziorski
Journal:  Genetics       Date:  2010-11-29       Impact factor: 4.562

5.  High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the Renin Angiotensin system.

Authors:  Silke Timmermans; Jeroen F J Bogie; Tim Vanmierlo; Dieter Lütjohann; Piet Stinissen; Niels Hellings; Jerome J A Hendriks
Journal:  J Neuroimmune Pharmacol       Date:  2013-09-26       Impact factor: 4.147

Review 6.  The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance.

Authors:  Ines Pagel-Langenickel; Jianjun Bao; Liyan Pang; Michael N Sack
Journal:  Endocr Rev       Date:  2009-10-27       Impact factor: 19.871

7.  The role of dysregulated glucose metabolism in epithelial ovarian cancer.

Authors:  L D Kellenberger; J E Bruin; J Greenaway; N E Campbell; R A Moorehead; A C Holloway; J Petrik
Journal:  J Oncol       Date:  2010-02-17       Impact factor: 4.375

8.  SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation.

Authors:  Amine Toubal; Karine Clément; Rongrong Fan; Patricia Ancel; Veronique Pelloux; Christine Rouault; Nicolas Veyrie; Agnes Hartemann; Eckardt Treuter; Nicolas Venteclef
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

Review 9.  Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination.

Authors:  Rudruidee Karnchanasorn; Horng-Yih Ou; James Lin; Lee-Ming Chuang; Ken C Chiu
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

Review 10.  Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin.

Authors:  Eduardo Esteve; Wifredo Ricart; José Manuel Fernández-Real
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.